Results 11 to 20 of about 11,360 (219)
European Annals of Otorhinolaryngology, Head and Neck Diseases, 2010 Although cholesteatoma was first described in 1683, its etiopathogeny remains unexplained. In children, there are two forms: acquired cholesteatoma, resembling the adult form, and congenital cholesteatoma. The acquired form has become less frequent in recent years, thanks to progress in the treatment of childhood otitic pathology.
Jérôme Nevoux, G Roger
exaly +4 more sources
A Recurrent Tympanicum Paraganglioma With a SDHD Pathogenic Variant: First Reported Case. [PDF]
World J Otorhinolaryngol Head Neck SurgABSTRACT Objective The aim of this study is to describe a clinical case of a SDHD germline mutation associated tympanic paraganglioma (TPGL). Patients A female patient seen in the otology clinic at a tertiary care center with a diagnosis of tympanic paraganglioma and significant family history of head and neck paragangliomas.
Graboyes AZ, Wong K, Huan Y, Brant JA.
europepmc +2 more sources
Endoscopic Management of Pediatric Cholesteatoma
Journal of Otology, 2020 Pediatric cholesteatoma occurs in one of two forms: congenital cholesteatoma, developing from embryonic epidermal cell rests or acquired cholesteatoma, associated with a focal defect in the tympanic membrane.
Peter J. Ryan, Nirmal P. Patel
doaj +2 more sources
Short-Term Complications Are Rare After Cholesteatoma Surgery. [PDF]
Clin OtolaryngolABSTRACT Objective To evaluate the incidence and nature of short‐term complications following cholesteatoma surgery in a heterogeneous cohort. Design A retrospective cohort study including complete coverage of cholesteatoma surgery in a Swedish region between 1 January 2005 and 31 December 2015.
Modée Borgström A +3 more
europepmc +2 more sources
Non‐coding RNA and cholesteatoma [PDF]
Laryngoscope Investigative Otolaryngology, 2022 Objective Cholesteatoma is a challenging chronic pathology of the middle ear for which pharmacologic therapies have not been developed yet. Cholesteatoma occurrence depends on the interplay between genetic and environmental factors while master ...
Ivan Jovanovic +3 more
doaj +2 more sources
Hearing loss assessment in primary and secondary acquired cholesteatoma, [PDF]
Brazilian Journal of Otorhinolaryngology, 2015 INTRODUCTION: Acquired middle ear cholesteatoma can be classified as primary or secondary. Although both can result in hearing loss, it is still controversial whether there is an association between the type of cholesteatoma and the degree of hearing ...
Julia Maria Olsen +3 more
doaj +2 more sources
Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma [PDF]
Clinical and Experimental Otorhinolaryngology, 2018 Objectives As endoscopic instrumentation, techniques and knowledges have significantly improved recently, endoscopic ear surgery has become increasingly popular. Transcanal endoscopic ear surgery (TEES) can provide better visualization of hidden areas in
Joo Hyun Park, Jungmin Ahn, Il Joon Moon
doaj +3 more sources
Menin-MLL inhibitors as a new therapeutic target for middle ear cholesteatoma [PDF]
Scientific ReportsMiddle ear cholesteatoma (cholesteatoma), also known as a cholesteatomatous chronic otitis media, is concerning because it expands into the middle ear with bone destruction and causes irreversible hearing loss.
Tomomi Yamamoto-Fukuda +2 more
doaj +2 more sources
Massive Temporal Lobe Cholesteatoma [PDF]
Case Reports in Otolaryngology, 2015 Introduction. Intracranial extension of cholesteatoma is rare. This may occur de novo or recur some time later either contiguous with or separate to the site of the original cholesteatoma. Presentation of Case.
Pasan Waidyasekara +4 more
doaj +2 more sources
Endoscopic Cholesteatoma Surgery. [PDF]
, 2022 Implementation of endoscopes in cholesteatoma surgery resulted in considerable changes in the management of cholesteatoma in the last two decades. Compared to the microscopic approach with an excellent but straight-line view and limited illumination, the
Anschuetz, Lukas +5 more
core +2 more sources